NR AKWH
AU Silei,V.; Fabrizi,C.; Venturini,G.; Salmona,M.; Bugiani,O.; Tagliavini,F.; Lauro,G.M.
TI Activation of microglial cells by PrP and beta-amyloid fragments raises intracellular calcium through L-type voltage sensitive calcium channels
QU Brain Research 1999 Feb 6; 818(1): 168-70
PT journal article
AB The prion protein (PrP) and the amyloid beta (Abeta) precursor protein (APP) are two normal proteins constitutively synthesised in human brain. An altered form of PrP accumulates in Creutzfeldt-Jakob disease, while Abeta is involved in the pathogenesis of Alzheimer's disease. Synthetic fragments of both proteins, PrP106-126 and beta25-35 (beta25-35), have been demonstrated to induce neurodegeneration and microglia activation. This study was undertaken to compare PrP106-126 and beta25-35 capability of activating human resting microglial cells. Our results show that both peptides are able to induce microglial activation and to elicit an increase in [Ca2+]i levels in cells loaded with calcium-green 1. Inhibitors of L-type voltage-sensitive calcium channels (verapamil, nifedipine and diltiazem) prevented the increase in [Ca2+]i concentration as observed after treatment with PrP106-126 and beta25-35, thus indicating a transmembrane calcium influx through these channels. In addition, verapamil abolished the proliferative effect of both PrP106-126 and beta25-35.
MH Amino Acid Sequence; Amyloid beta-Protein/chemistry/*pharmacology; Brain/cytology/drug effects/embryology; Calcium/*metabolism; Calcium Channel Blockers/pharmacology; Calcium Channels/*drug effects; Human; Membrane Potentials/drug effects; Microglia/*drug effects; Molecular Sequence Data; Peptide Fragments/*pharmacology; Prions/*pharmacology; Support, Non-U.S. Gov't
AD Dipartimento di Biologia, Universita di Roma Tre, V.le Marconi n. 446, 00146, Rome, Italy.
SP englisch
PO Niederlande